Mount Sinai Health System
Search
Profile image of Stuart C Sealfon

    Stuart C Sealfon, MD

    Education

    MD, Columbia-Presbyterian Medical Center

    Awards

    2008

    ''Identification of a serotonin/glutamate receptor complex implicated in psychosis'' rated ''Exceptional'' by Faculty of 1000, Biology, and ''Must Read'' by Faculty of 1000, Medicine

    Faculty of 1000, Medicine

    2007

    ''BioPP: a tool for web-publication of biological networks'' rated ''Highly Accessed,'' BMC Bioinformatics

    2006

    ''Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice'' rated ''Recommended'' by Faculty of 1000, Biology

    2004

    ''Early single cell bifurcation of pro-and anti-apoptotic states during oxidative stress'' rated ''Must Read'' by Faculty of 1000, Biology

    1988

    Physician-Scientist Award

    NIH

    1982

    Alpha Omega Alpha

    Columbia University

    1982

    Sciarra Prize in Neurology

    Columbia University College of Physicians and Surgeons

    1982

    Sandoz Award for Neuroscience Research

    Columbia University College of Physicians and Surgeons

    1978

    Phi Beta Kappa

    Princeton University

    Research

    Specific Clinical/Research Interest: Systems biology of cellular signaling specificity in response to drugs or viruses

    Current Students: Tony Yuen, Rosalind Ang, Soon-Gang Choi, David Braun

    Postdoctoral Fellows: Jeremy Seto, Boris Hartmann, Joanna Gonzalez, Robert Bowles, Liang Qiao, Laura Abizu

    Research Personnel: Science Admin: Lidija Ivic, Bioinformatics: Hanna Pincus, Computer Systems: German Nudelman, Techs: Ke Jiang, Esther Rhee, Ming Chen

    Associated Faculty: Fernand Hayot, Robert Pfeffer, YongChao Ge Istvan Sugar

    Summary of Research Studies:
    We use high throughput experiments and modeling to study signaling systems that are important for understanding cellular responses relevant to Parkinson's disease, drug abuse, viral infection and neuroendocrine reproductive function. We are interested in elucidating the molecular mechanisms underlying receptor activation and coupling to signal transduction and in placing these events in a cellular and neurobiological context. The ultimate neurobehavioral effects of an agonist evolve from the specific molecular events that accompany the interaction with its receptor and the pattern of signal transduction that is elicited. How does a specific chemical stimulus lead to the resulting downstream cellular response? In order to address this deceptively simple question we have developed new approaches to study the mechanisms underlying signal coding and signaling specificity of G-protein coupled receptors and to study responses at the single cell level in complex systems. We are investigating these issues in several experimental systems.

    1) Frequency-dependent Responses of the Gondotropin-Releasing Hormone Receptor. The GnRH-R is a key mediator of the reproductive neuroendocrine system and represents a key pharmaceutical target for neoplastic and reproductive disorders. The downstream gene responses obtained in the pituitary gonadotrope depend on the frequency of receptor activation. Using gene profiling technologies, we are probing the modulation of the signaling space induced by GnRH receptor activation and developing mathematical models to explain the basis for the frequency-dependence of the pattern of gene induction.

    2) Receptor Determinants of Hallucinogen Effects. Hallucinogenic drugs of abuse, such as LSD, generate their psychotropic effects through their interaction with 5-HT2 subtype receptors and the serotonin-glutamate receptor complex we have recently identified.

    3) Experiment-based modeling of dendritic cell responses to viruses: We are developing experimental-data based predictive mathematical models of dendritic cell responses to pathogenic viruses.

    For more information, please visit the Sealfon Laboratory website.